Tatva Chintan Pharma Chem Limited (TATVA.NS)

Home
TATVA.NS
Financials

856.35 (INR) • At close November 4, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	834.9	1,054.64	982.66	842.06	966.69	1,143.64	1,245.12	1,206.07	900.91	884.02	961.76	1,046.7	1,236.15	1,068.32	1,051.65	801.17	600.43	515.32
Cost of Revenue Numbers are in millions	427.21	763.59	620.77	373.42	373.14	580.48	750.08	677.97	434.46	398.5	542.76	451.86	550.1	532.06	634.76	321.25	336.12	262.53
Gross Profit Numbers are in millions	407.69	291.05	361.89	468.64	593.55	563.16	495.04	528.1	466.45	485.52	419	594.84	686.05	536.26	416.89	479.92	264.31	252.79
Gross Profit Ratio Numbers are in millions	0.488	0.276	0.368	0.557	0.614	0.492	0.398	0.438	0.518	0.549	0.436	0.568	0.555	0.502	0.396	0.599	0.44	0.491
Reseach & Development Expenses Numbers are in millions	0	0	0	0	0	0	60.39	0	0	0	37.07	0	0	0	7.04	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	222.43	231.55	268.13	211.04	140.69	115.62	229.02	244.02	262.72	85.81	91.54	82.23	74.54	206.67	68.69	71.18	53.6	47.59
Other Expenses Numbers are in millions	419.95	11.73	45.28	12.1	7.56	10.15	8.45	15.2	15.49	18.29	-91.6	47.24	28.04	13.22	-28.92	6.55	19.48	0
Operating Expenses Numbers are in millions	419.95	231.55	268.13	424.53	458.84	409.85	357.57	372.8	377.76	356.69	206.1	377.52	347.68	292.48	173.64	250.61	217.48	164.48
Operating Income Numbers are in millions	-12.26	59.5	93.76	56.21	134.71	153.31	145.92	170.5	104.18	128.83	209.81	217.32	338.37	257	250.62	235.84	66.31	86.63
Operating Income Ratio Numbers are in millions	-0.015	0.056	0.095	0.067	0.139	0.134	0.117	0.141	0.116	0.146	0.218	0.208	0.274	0.241	0.238	0.294	0.11	0.168
Total Other Income Expenses Net Numbers are in millions	2.05	8.59	43.14	-3.77	-22.58	-19.11	-67.86	-28.27	-13.6	8.12	-20.05	37.36	15.8	-14.39	-8.23	-11.09	-9.87	-3.27
Income Before Tax Numbers are in millions	-10.21	68.09	136.9	52.44	112.13	134.2	78.06	142.23	90.58	136.95	189.76	254.68	354.17	242.61	242.39	224.75	56.44	83.36
Income Before Tax Ratio Numbers are in millions	-0.012	0.065	0.139	0.062	0.116	0.117	0.063	0.118	0.101	0.155	0.197	0.243	0.287	0.227	0.23	0.281	0.094	0.162
Income Tax Expense Numbers are in millions	-3.57	16	40.76	17.89	34.32	39.16	-91.53	26	19.46	38.98	14.66	26.61	30.05	11.15	31.2	16	20.88	16.26
Net Income Numbers are in millions	-6.64	52.09	96.14	34.55	77.81	95.04	169.59	116.23	71.12	97.97	175.1	228.07	324.12	231.46	211.19	208.75	35.56	67.1
Net Income Ratio Numbers are in millions	-0.008	0.049	0.098	0.041	0.08	0.083	0.136	0.096	0.079	0.111	0.182	0.218	0.262	0.217	0.201	0.261	0.059	0.13
EPS Numbers are in millions	-0.29	2.23	4.11	1.48	3.43	4.29	7.65	5.24	3.21	4.42	7.9	10.29	15.02	10.44	10.51	10.39	1.77	3.34
EPS Diluted Numbers are in millions	-0.29	2.23	4.11	1.48	3.43	4.29	7.65	5.24	3.21	4.42	7.9	10.29	15.02	10.44	10.51	10.39	1.77	3.34
EBITDA Numbers are in millions	59.64	126.15	156.09	122.04	210.04	223.58	171.23	194.33	127.26	170.45	217.06	285.32	386.98	275.98	268.37	251.75	83.15	97.878
EBITDA Ratio Numbers are in millions	0.071	0.12	0.159	0.145	0.217	0.195	0.138	0.161	0.141	0.193	0.226	0.273	0.313	0.258	0.255	0.314	0.138	0.19

Tatva Chintan Pharma Chem Limited

NSE:TATVA.NS Add to watchlist

NSE:TATVA.NS